HILLSIDE, NJ / ACCESSWIRE / November 13, 2024 / Integrated BioPharma, Inc. (OTCQX:INBP) (the "Company" or "INBP") reports its financial results for the quarter ended September 30, 2024. Revenue for the quarter ended September 30, 2024 was $13.6 million compared to $12.9 million for the quarter ended September 30, 2023, an increase of $0.7 million or approximately 5.4%.
HILLSIDE, NJ / ACCESSWIRE / September 20, 2024 / Integrated BioPharma, Inc. (OTCQX:INBP) (the "Company" or "INBP") reports its financial results for the quarter and fiscal year ended June 30, 2024. Revenue for the quarter ended June 30, 2024 was $12.7 million compared to $13.0 million for the quarter ended June 30, 2023, a decrease of $0.3 million or 2.3%.
| Food Products Industry | Consumer Staples Sector | Ms. Riva Kay Sheppard CEO | OTCQB Exchange | US45811V1052 ISIN |
| United States Country | 147 Employees | - Last Dividend | - Last Split | - IPO Date |
Integrated BioPharma, Inc. is a corporation that consolidates its efforts in the nutraceutical industry by manufacturing, distributing, marketing, and selling a broad spectrum of vitamins, nutritional supplements, and herbal products. With its primary markets located in the United States and Luxembourg, the company is structured to operate through two main segments: Contract Manufacturing and Other Nutraceutical Businesses. Originally founded in 1980 as Integrated Health Technologies, Inc., the company underwent a rebranding to better reflect its dedicated involvement in the biopharmaceutical sector. Integrated BioPharma, Inc. has established its headquarters in Hillside, New Jersey, positioning itself as a key player in the health and wellness industry.
The product offerings and services of Integrated BioPharma, Inc. are designed to cater to a broad spectrum of needs in the nutraceutical market, spanning from manufacturing services to direct-to-consumer products.
This segment of Integrated BioPharma focuses on the manufacturing of vitamins and nutritional supplements destined for distributors, multilevel marketers, and specialized healthcare providers. By offering contract manufacturing services, the company serves as a backbone for numerous brands, ensuring high-quality production of their health products.
Under this segment, Integrated BioPharma distributes a range of nutritional products through various retail channels including mass market, grocery, drug stores, and vitamin shops. The products marketed under this segment include: